Dr Lawrie Bott

Dr Lawrie Bott has had extensive work experience in the field of pathology. Dr Lawrie served as the Chief Medical Officer for Sonic Pathology Australia at Sonic Healthcare from February 2017. Additionally, they held the position of President at The Royal College of Pathologists of Australasia (RCPA) from November 2021. Dr Lawrie was also a Board Member at the National Association of Testing Authorities, Australia from November 2019 to September 2021. Dr Bott served as the Chief Executive Officer of Southern.IML Pathology from April 2000 to September 2021. Dr Lawrie was previously a Board Member at The Royal College of Pathologists of Australasia (RCPA) from 2013 to 2021. Dr Lawrie also held positions as a Board Member at Quality Assurance Programmes Pty Ltd from 1999 to 2017, as well as the Chief Executive Officer of Diagnostic Services Pty Ltd from 2006 to 2016. Prior to that, they served as the Chief Executive Officer of Barratt & Smith Pathology from 1990 to 2000.

Dr. Lawrie Bott completed their education in a chronological manner. Dr Lawrie began their academic journey in 1971 at the University of Sydney, where they pursued a degree in Medicine. After five years of dedicated study, they successfully obtained their MBBS (Hons) in 1976.

Years later, from 1983 to 1989, Dr. Bott continued their education by becoming a Fellow of the Royal College of Pathologists of Australasia. This prestigious accomplishment allowed him to specialize in the field of Pathology.

Their most recent educational endeavor commenced in 2016 and is expected to conclude in 2025. During this period, they are attending the Australian Institute of Company Directors with the goal of earning their Graduate of the Australian Institute of Company Directors (GAICD) degree. The specific field of study for this program was not provided.

Based on the given information, it can be concluded that Dr. Lawrie Bott has a diverse and comprehensive educational background, ranging from medicine to pathology and corporate governance.